Certis Biologicals

Certis Biologicals is a leading player in the field of biological pesticides, offering a comprehensive range of biopesticides and related services. With expertise in biological product development, manufacturing, global registrations, and sales channels, the company operates in over 30 countries. The company's roots can be traced back to the formation of Thermo Trilogy in 1996 and subsequent acquisitions, including Neem Technologies from W.R. Grace, baculovirus products from Biosys, and Bt bioinsecticide products from Novartis and Ecogen.

In 2001, Mitsui & Co., a prominent Japanese trading company, acquired Thermo Trilogy and rebranded it as Certis U.S.A. L.L.C. as part of Mitsui's AgriScience Division. Since then, Certis Biologicals has been positioned as the global competence center for biological control technologies within Mitsui. The company has established itself as a manufacturer and distributor of high-quality bioproducts and active ingredients, firmly establishing its presence in the Biotechnology, Design, and Health Care industries.

Although the headquarters information and details about the last investment and investors are not provided in the available data, Certis Biologicals' track record and industry positioning make it an attractive proposition for potential investors looking to capitalize on the growing demand for sustainable and eco-friendly pest management solutions.